Journal of Electrocardiology
Volume 43, Issue 1 , Pages 84-86 , January 2010

Optimum way to evaluate the quality of QT interval measurement in pharmaceutical studies

Received 20 June 2009

References 

  1. Lewicke A, Bellor K, Dillon K, Kaib T, Szymkiewicz S, Schuckers S. Exploring QT interval changes as a precursor to the onset of ventricular fibrillation/tachycardia. J Electrocardiol. 2009;42:374
  2. Samuelov-Kinori L, Kinori M, Kogan Y, et al. Takotsubo cardiomyopathy and QT interval prolongation: who are the patients at risk for torsades de pointes?. J Electrocardiol. 2009;42:353
  3. Sarapa N, Gussak I, Vajdic B, et al. Comparison of QTinno, a fully automated electrocardiographic analysis program, to semiautomated electrocardiographic analysis methods in a drug safety study in healthy subjects. J Electrocardiol. 2009;42:358
  4. Chinushi M, Iijima K, Tagawa M, Komura S, Furushima H, Aizawa Y. Effects of vrapamil on anterior ST segment and ventricular fibrillation cycle length in patients with Brugada syndrome. J Electrocardiol. 2009;42:367
  5. Panicker GK, Karnad DR, Natekar M, Kothari S, Narula D, Lokhandwala Y. Intra- and interreader variability in QT interval measurement by tangent and threshold methods in a central electrocardiogram laboratory. J Electrocardiol. 2009;42:348
  6. E14 clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs. Guidance to industry. Fed Regist. 2005;70:61134
  7. Darpo B, Agin M, Kazierad DJ, et al. Man versus machine: is there an optimal method for QT measurements in thorough QT studies?. J Clin Pharmacol. 2006;46:598
  8. Fosser C, Duczynski G, Agin M, Wicker P, Darpo B. Comparison of manual and automated measurements of the QT interval in healthy volunteers: an analysis of five thorough QT studies. Clin Pharmacol Ther. 2009;[in press]
  9. Yang H, Bukkapatnam ST, Komanduri R. Nonlinear adaptive wavelet analysis of electrocardiogram signals. Phys Rev E Stat Nonlin Soft Matter Phys. 2007;76:026214
  10. Chen PC, Lee S, Kuo CD. Delineation of T-wave in ECG by wavelet transform using multiscale differential operator. IEEE Trans Biomed Eng. 2006;53:1429
  11. Strachan IG, Hughes NP, Poonawala MH, Mason JW, Tarassenko L. Automated QT analysis that learns from cardiologist annotations. Ann Noninvasive Electrocardiol. 2009;14(Suppl 1):S9
  12. Malik M. Errors and misconceptions in ECG measurement used for the detection of drug induced QT interval prolongation. J Electrocardiol. 2004;37(Suppl):25
  13. Zhang J, Machado SG. Statistical issues including design and sample size calculation in thorough QT/QTc studies. J Biopharm Stat. 2008;18:451
  14. Malik M, Hnatkova K, Batchvarov V, Gang Y, Smetana P, Camm AJ. Sample size, power calculations, and their implications for the cost of thorough studies of drug induced QT interval prolongation. Pacing Clin Electrophysiol. 2004;27:1659
  15. Hnatkova K, Smetana P, Toman O, Bauer A, Schmidt G, Malik M. Systematic comparisons of electrocardiographic morphology increase the precision of QT interval measurement. Pacing Clin Electrophysiol. 2009;32:119
  16. Malik M, Andreas JO, Hnatkova K, et al. Thorough QT/QTc study in patients with advanced Parkinson's disease: cardiac safety of rotigotine. Clin Pharmacol Ther. 2008;84:595
  17. Malik M, Hnatkova K, Ford J, Madge D. Near-thorough QT study as part of a first-in-man study. J Clin Pharmacol. 2008;48:1146

PII: S0022-0736(09)00262-3

doi: 10.1016/j.jelectrocard.2009.06.018

Journal of Electrocardiology
Volume 43, Issue 1 , Pages 84-86 , January 2010

Article Tools

* Image Usage & Resolution